Nomura Holdings’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Nomura Holdings’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34,200	Closed	-$371K	–	1700
2023 Q2	$371K	Sell	34,200 -266,800	-89%	-$2.28M	﹤0.01%	1091
2023 Q1	$2.08M	Buy	301,000 +117,400	+64%	+$736K	0.01%	803
2022 Q4	$732K	Buy	183,600 +52,700	+40%	+$259K	﹤0.01%	898
2022 Q3	$871K	Buy	+130,900	New	+$806K	﹤0.01%	989

Other funds holding MRNS

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Nomura Holdings's MRNS Position: Q1 2023 in Review

Nomura Holdings sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2023, closing a stake of 58,816 shares — an estimated $369K sold.

Nomura Holdings first reported a position in MRNS in Q3 2022 and held it in 2 quarters. The position peaked at $234K in Q4 2022. 86 funds tracked by Wall St. Rank hold MRNS as of Q1 2023.

Nomura Holdings reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2023 after selling out during the quarter.
Nomura Holdings sold 58,816 Marinus Pharmaceuticals, Inc shares in Q1 2023, an estimated $369K.
Nomura Holdings first reported a position in Marinus Pharmaceuticals, Inc in Q3 2022 and held it in 2 quarters.
Nomura Holdings's Marinus Pharmaceuticals, Inc position peaked at $234K in Q4 2022.
86 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.